China, Nov. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase II clinical study evaluating the efficacy and safety of IBI3016 in Chinese patients with mild to moderate hypertension'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136939

Registration Time: 2026/11/17

Type: Interventional study

Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=319296

Published by HT Digital Content Services with permission from Health Daily Digest....